REFERENCES
- Baker R.W., U.S. Patent 3,952,741, 1976, Assigned to Bend Research Inc., Bend Oreg
- Niwa K., Takaya T., Morimoto T., Takada K. J. Drug Target 1995; 3: 83–89
- Jimoh A.G., Wise D.L., Gresser J.D., Trantolo D.J. J. Contr. Rel. 1995; 34: 87–95
- Handbook of Pharmaceutical Excipients, 2nd Ed. The American Pharmaceutical Association and The Royal Pharmaceutical Society of Great Britain. 1994; 186–190
- Bottenberg P., Claymaek R., de Muynck C., Remon J.P., Coomans D., Michotte Y., Slop D. J. Pharm. Pharmacol. 1991; 43(7)457–464
- Kim C.J. Pharm. Res. 1995; 12(Jul)1045–1048
- Yang L., Venkatesh G., Fassihi R. Int. J. Pharm. 1997; 152: 45–52
- Swanson D.R., Barclay B.L., Wong P.S.L., Theeuwes F. Am. J. Med. 1987; 83(Suppl. 6B)3–9
- Wong P.S.L., Barclay L., Deters J.C., Theeuwes F., U.S. Patent 4,765,989, 1988
- Theeuwes F. J. Pharm. Sci. 1975; 64: 1987–1991
- Washburn E.W. Phys. Rev. 1921; 17: 273–283
- Strickland W.A., Busse L.W., Highuchi T. J. Am. Pharm. Assoc. 1956; 45: 187–197
- Razaghi A.M., Schwartz J.B. Investigation of Cyclobenzaprine Hydrochloride Release from Oral Osmotic Delivery Systems Containing a Water Swellable Polymer. Drug Dev. Ind. Pharm. 2002; 28(6)697–703